Insights & Resources

Learn what the new U.S. cyber strategy and cybercrime executive order signal for organizations and how security leaders can prepare for evolving threats.

Is your transaction a business combination or asset acquisition? Learn how ASC 805 guidance, the screen test and key differences shape reporting.

Texas life sciences in 2025 saw concentrated capital, declining innovation output and earlier‑stage clinical shifts shaping the ecosystem.

Texas life sciences saw record capital in Q4 2025, even as innovation, early-stage funding and late-phase clinical trials continued to decline.

Cyber insurers are raising the bar on security. Learn what underwriting trends reveal about organizational resilience and how leaders can prepare.

Colleges face rising fraud from “ghost students.” Learn how to detect fake enrollments, strengthen controls and protect aid funds.

Health care providers face rising risks in privacy, AI and HIPAA enforcement. Find out what hospitals can do now to strengthen compliance efforts.

J.P. Morgan's Q1 2025 biopharma and medtech reports reveal larger deals, global growth and financial strategies shaping the life sciences industry.

Artificial intelligence (AI) is reshaping security, from threat detection to risk management. Explore the top three security measures for effective AI integration.

Learn about the key updates in ISO 27001:2022, including new climate change considerations and what your organization must do to stay compliant.

Within the changing landscape of educational technology, schools face new risk factors that affect students, faculty and administrators.

Explore ASC 805’s role in bringing clarity to business combinations — from fair value measurements to goodwill and beyond.